Expression of early growth response factor 1 and intervention of silymarin in rat models of alcoholic fatty live

doi:10.3969/j.issn.2095-4344.2015.27.016

Abstract

Abstract:

BACKGROUND: Proinflammatory transcription factors and inflammatory factors play an important role in the occurrence of alcoholic liver disease. However, early growth response factor 1 is one of the key factors of starting inflammation.
OBJECTIVE: To investigate and analyze the effects of silymarin on early growth response factor1 in rat models of alcoholic fatty liver.
METHODS: The rat models were established using the methods of feeding with high fat diet and intragastrically administering alcohol, in total 8 weeks. Silymarin intervention at high and low doses (200,100 mg/kg) was given after each gavage. The normal group was set as comparison.
RESULTS AND CONCLUSION: Serological indicator detection and hematoxylin-eosin staining results showed that compared with the model group, the body weight of rats was increased (P < 0.05); serum aspartate aminotransferase, alanine aminotransferase activity, early growth response factor 1 and tumor necrosis factor-α expression in the liver tissue were decreased (P < 0.05); pathological grading results were superior in the high-dose silymarin group to in the other groups (P < 0.01). The results confirm that high dose of silymarin can protect the liver function of rats, reduce the occurrence of liver function damage, which may be associated with the inhibition on the early growth response factor 1 in the body of rats, thereby reducing the tumor necrosis factor-α formation, but the specific mechanism remains to be further studied.

中国组织工程研究杂志出版内容重点：肾移植；肝移植；移植；心脏移植；组织移植；皮肤移植；皮瓣移植；血管移植；器官移植；组织工程

CLC Number:

R318

Zhou Hong-xing. Expression of early growth response factor 1 and intervention of silymarin in rat models of alcoholic fatty live[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(27): 4351-4355.

Figures/Tables 7

References

[1] 孙屹峰,郭李柯,秦咏梅,等.参芪扶正注射液对乙醇性肝纤维化大鼠ROS, SOD, LPO, NF-κB及CTGF mRNA表达的干预作用[J].世界华人消化杂志,2012,20(16):1463-1467.

[2] 田图磊.Egr-1在大鼠乙醇性脂肪肝中的表达及水飞蓟素对其干预作用[D].合肥:安徽医科大学,2013.

[3] 孙惠,赵彩彦.肿瘤坏死因子α在非乙醇性脂肪性肝病中的作用机制及其综合治疗[J].河北医药,2009,31(15):1978-1978.

[4] 田图磊,洪汝涛,徐德祥,等.Egr-1在大鼠乙醇性脂肪肝中的表达及水飞蓟素对其干预作用[J].安徽医药,2013,01(21):23-26.

[5] 田德安,洪捷敏,刘南植,等.L-精氨酸对乙醇性肝脂肪变大鼠肝组织NOS表达及氧应激的影响[J].世界华人消化杂志, 2004,12(3): 702-705.

[6] 谭海荣,吴谦,潘竞锵,等.水飞蓟宾对抗大鼠乙醇性脂肪肝作用及机制[J].中国临床药理学与治疗学,2004,9(7):803-806.

[7] 徐光福,褚月虎,王晓阳,等.中药调肝理脾方对大鼠乙醇性肝病肝纤维化的影响[J].世界华人消化杂志,2006,14(24):2386-2394.

[8] 梁基智,林洁茹,谭海荣,等.水飞蓟宾对抗大鼠乙醇性脂肪肝改善肝功能的作用[J].中国临床康复,2006,10(7):183-185.

[9] 杨慧莹,林克荣.水飞蓟素治疗脂肪肝的作用机制[J].中华现代内科学杂志,2006,3(8):876-878.

[10] 陈世林,洪汝涛,刁磊,等.水飞蓟素对大鼠急性乙醇性肝损伤的保护作用[J].安徽医科大学学报,2010,(2):209-212.

[11] 苗羊,金瑞.当飞利肝宁对实验大鼠乙醇性肝损伤防治作用的实验研究[J].中医杂志,2003,44(1):21-22.

[12] Woo SM, Min KJ, Kim S, et al. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chem Biol Int. 2014;21(1):32-34.

[13] Hahn SS, Tang Q, Zheng F, et al. GW1929 inhibits α7 nAChR expression through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR: the role of Egr-1. Cell Signal. 2014;2(64):15-17.

[14] Schreiber WB, Asok A, Jablonski SA, et al. Egr-1 mRNA expression patterns in the prefrontal cortex, hippocampus, and amygdala during variants of contextual fear conditioning in adolescent rats. Brain Res. 2014;15(76):23-25.

[15] Klenke S, Rump K, Buschkamp K, et al. Characterization of the PLCB1 promoter and regulation by early growth response transcription factor EGR-1. Eur J Pharmacol. 2014;74(2):14-16.

[16] Zhang BL, Ni HB, Liu J, et al. Egr-1 participates in abnormally high gdnf gene transcription mediated by histone hyperacetylation in glioma cells. Biochim Biophys Acta. 2014; 18(3911):12-13.

[17] 祁慧,薛斌,祁慧,等. EGR-1在肝损伤中的作用[J].世界华人消化杂志,2011,19(18):1914-1921.

[18] 宋奎,何群.抗氧化剂An7845对K562白血病细胞的增殖抑制和凋亡诱导活性[J].中南大学学报(医学版),2004,29(3):257-260.

[19] 谢正元,文艺,张吉翔.5-脂氧合酶与肝脏疾病[J].世界华人消化杂志,2004,12(8):1905-1908.

[20] Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol. 2000; 12(11):1047-1049.

[21] Fan YY, Ye GH, Lin KZ, et al. Time-dependent expression and distribution of Egr-1 during skeletal muscle wound healing in rats. J Mol Histol. 2013;44(1):75-81.

[22] 邹岚,朱波,陈敬,等.pEgr-MIP3α重组质粒的构建及其在Lewis 肺癌细胞中的辐射诱导表达[J].重庆医学,2004,33(7):968-970.

[23] 李灏,姜颖,贺福初.乙醇肝毒性及治疗的研究进展[J].中国药理学与毒理学杂志,2008, 22(5):396-400.

[24] Asok A, Schreiber WB, Jablonski SA, et al. Egr-1 increases in the prefrontal cortex following training in the context preexposure facilitation effect (CPFE) paradigm. Neurobiol Learn Mem. 2013;106:145-153.

[25] 于乐成,顾长海.水飞蓟素与乙醇性肝病[J].肝脏,2000,5(3): 182-183.

[26] 冷亮,蒋卓勤,纪桂元,等.抗氧化剂防治非乙醇性脂肪肝的研究进展[J].现代预防医学,2012,39(3):564-565.

[27] Weaver IC, Hellstrom IC, Brown SE, et al. The methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptor. Philos Trans R Soc Lond B Biol Sci. 2014;369(1652).

[28] Katche C, Goldin A, Gonzalez C, et al. Maintenance of long-term memory storage is dependent on late posttraining Egr-1 expression. Neurobiol Learn Mem. 2012;98(3):220-227.

[29] Brown KC, Lau JK, Dom AM, et al. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. Angiogenesis. 2012;15(1):99-114.

[30] 古颖娴,吴谦,陈少娟,等.茵陈蒿汤对抗大鼠乙醇性脂肪肝作用[J].中国新医药,2004,3(7):17-19.